Find comprehensive market research and company reports on the AntiSense & RNAi Technology Industry. More specifically, find reports on the Cancer Therapies, Bioinformatics and Bioprocessing markets. Reports include data on market segmentation, size and growth in US, UK, Europe, Asia and global markets.
All reports in Antisense & RNAi Technology
|
2012 European Nucleic Acid Testing Market: France, Germany, Italy, Spain, UK Emerging Opportunities and Business Expansion Strategies
4/24/2012 | published by: Venture Planning Group
... and technological trends in major European countries (France, Germany, Italy, Spain, UK); provides 5-year test volume/sales forecasts; estimates shares of leading competitors; compares features of major analyzers; profiles leading market players; and identifies specific product ...
|
more...
|
$18,500.00
|
|
2012 Global Nucleic Acid Testing Market Outlook: Growth Opportunities and Strategies
4/23/2012 | published by: Venture Planning Group
... seven major markets Five- and ten-year test volume and sales forecasts Market shares of leading competitors Feature comparison of major analyzers Profiles of market players and start-up firms developing innovative technologies and products Specific product ...
|
more...
|
$28,500.00
|
|
Global RNAi Market Analysis
4/1/2012 | published by: RNCOS
... in the basic research. Our latest research found that various components, such as siRNA & miRNA possess immense opportunities and provide a wide range in different drug classes. These molecules also find wide applications in ...
|
more...
|
$1,300.00
|
|
RNA Interference Therapy in Oncology Drug Pipeline Update 2012
2/21/2012 | published by: BioSeeker Group AB
... in 75 developmental projects in cancer. In addition, the accumulated number of ceased drugs over the last years amount to another 23 drugs. Rna Interference Therapy In Oncology Drug Pipeline Update lists all drugs and ...
|
more...
|
$1,499.00
|
|
Nucleic Acid Therapies in Oncology Drug Pipeline Update 2012
2/21/2012 | published by: BioSeeker Group AB
... therapy drugs in 520 developmental projects in cancer. In addition, there are 7 suspended drugs and the accumulated number of ceased drugs over the last years amount to another 177 drugs. Nucleic Acid Therapies In ...
|
more...
|
$2,249.00
|
|
Future Nucleic Acid Testing Market--New Product Development Opportunities and Business Expansion Strategies for Instrument and Reagent Suppliers
2/14/2012 | published by: Venture Planning Group
... seven major markets Five- and ten-year test volume and sales forecasts Market shares of leading competitors Feature comparison of major analyzers Profiles of market players and start-up firms developing innovative technologies and products Specific product ...
|
more...
|
$28,500.00
|
|
Future Infectious Disease Nucleic Acid Testing
2/14/2012 | published by: Venture Planning Group
... products. Contains 360 pages and 20 tables Please note: The delivery time for the electronic version of this report is between 1-3 business days to allow the preparation of an updated version prior to dispatch.
|
more...
|
$2,500.00
|
|
Emerging Opportunities in Cancer Nucleic Acid Testing
2/14/2012 | published by: Venture Planning Group
... products for cancer testing. Contains 45 pages Please note: The delivery time for the electronic version of this report is between 1-3 business days to allow the preparation of an updated version prior to dispatch.
|
more...
|
$1,450.00
|
|
Future German Nucleic Acid Testing Market Outlook
2/14/2012 | published by: Venture Planning Group
... impact during the next ten years. An extensive review of DNA probe and biochip technologies, test formats, detection methodologies, trends in testing automation and amplification methods. Ten-year test volume and reagent sales forecasts for the ...
|
more...
|
$5,900.00
|
|
Future Italian Nucleic Acid Testing Market Outlook
2/14/2012 | published by: Venture Planning Group
... impact during the next ten years. An extensive review of DNA probe and biochip technologies, test formats, detection methodologies, trends in testing automation and amplification methods. Ten-year test volume and reagent sales forecasts for the ...
|
more...
|
$5,900.00
|
|
Future Spanish Nucleic Acid Testing Market Outlook
2/14/2012 | published by: Venture Planning Group
... impact during the next ten years. An extensive review of DNA probe and biochip technologies, test formats, detection methodologies, trends in testing automation and amplification methods. Ten-year test volume and reagent sales forecasts for the ...
|
more...
|
$5,900.00
|
|
Future US Nucleic Acid Testing Market Outlook
2/14/2012 | published by: Venture Planning Group
... impact during the next ten years. An extensive review of DNA probe and biochip technologies, test formats, detection methodologies, trends in testing automation and amplification methods. Ten-year test volume and reagent sales forecasts for the ...
|
more...
|
$8,400.00
|
|
Leading Nucleic Acid testing Market Players
2/14/2012 | published by: Venture Planning Group
... Collaborative arrangements Business strategies Contains 120 pages Please note: The delivery time for the electronic version of this report is between 1-3 business days to allow the preparation of an updated version prior to dispatch.
|
more...
|
$2,500.00
|
|
Future French Nucleic Acid Testing Market Outlook
2/14/2012 | published by: Venture Planning Group
... impact during the next ten years. An extensive review of DNA probe and biochip technologies, test formats, detection methodologies, trends in testing automation and amplification methods. Ten-year test volume and reagent sales forecasts for the ...
|
more...
|
$5,900.00
|
|
Future Japanese Nucleic Acid Testing Market Outlook
2/14/2012 | published by: Venture Planning Group
... impact during the next ten years. An extensive review of DNA probe and biochip technologies, test formats, detection methodologies, trends in testing automation and amplification methods. Ten-year test volume and reagent sales forecasts for the ...
|
more...
|
$7,500.00
|
|
Future UK Nucleic Acid Testing Market Outlook
2/14/2012 | published by: Venture Planning Group
... impact during the next ten years. An extensive review of DNA probe and biochip technologies, test formats, detection methodologies, trends in testing automation and amplification methods. Ten-year test volume and reagent sales forecasts for the ...
|
more...
|
$5,900.00
|
|
Cell-Based Assays: World Market Prospects 2012-2022
1/23/2012 | published by: Visiongain
... activities of product developers and pre-clinical contract research organisations. You discover sales predictions to 2022 at world market, main submarket and national levels. Find potential revenues for products and services. Also, you receive discussions of ...
|
more...
|
$2,642.00
|
|
Nucleic Acid Purification Life Science Dashboard™ Series 3
9/11/2011 | published by: Percepta Associates, Inc.
... Dashboard was developed from responses to a 20-question survey of 506 scientists predominantly located in North America and Europe. This Dashboard reveals key market indicators for the nucleic acid purification market as a whole as ...
|
more...
|
$3,975.00
|
|
Nucleic Acid Amplification Life Science Dashboard™ Series 3
9/1/2011 | published by: Percepta Associates, Inc.
... expression. The Nucleic Acid Amplification Dashboard was developed from responses to a 21-question survey by 492 scientists predominantly located in North America and Europe. This Dashboard reveals key market indicators for the nucleic acid amplification ...
|
more...
|
$3,975.00
|
|
Conference Documentation: RNAi, miRNA & siRNA
6/28/2011 | published by: SMI Publishing, Ltd
... issues that stand in the way of the successful harnessing of the vast potential that the process possesses. RNAi is still a new and exciting area of pharmaceutical development, however significant progress is required in ...
|
more...
|
$800.00
|
|
Lead Generation Strategies and Technologies in Drug Development - Emerging Techniques Such as Antisense Technology Will Allow Innovators to Minimize Costs
6/10/2011 | published by: GBI Research
... Drug Development - Emerging Techniques Such as Antisense Technology Will Allow Innovators to Minimize Costs” that provides key data, information and analysis of the major trends and developments in the drug devleopment business. The report ...
|
more...
|
$3,500.00
|
|
Global Nucleic Acid Testing Market--New Product Development Opportunities and Business Expansion Strategies For Instrument and Reagent Suppliers
6/1/2011 | published by: Venture Planning Group
... seven major markets Five- and ten-year test volume and sales forecasts Market shares of leading competitors Feature comparison of major analyzers Profiles of market players and start-up firms developing innovative technologies and products Specific product ...
|
more...
|
$28,500.00
|
|
RNA interference (RNAi)
4/1/2011 | published by: Global Industry Analysts
... US, Canada, Japan, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2009 through 2017. Also, a six-year historic analysis is provided for these markets. The report profiles 136 ...
|
more...
|
$4,800.00
|
|
RNAi for Therapeutic Applications: Market Prospects 2011-2021
3/29/2011 | published by: Visiongain
... aim to save you time and aid your decisions through our research, data and discussions. You can stay ahead by ordering our report now. Our new study shows you revenue prospects for RNAi technologies at ...
|
more...
|
$2,331.00
|
|
Competitor Analysis RNA Therapeutics in Clinical Development
3/1/2011 | published by: La Merie Publishing
... as of February 2011. RNA based Therapetuics include antisense molecules, aptamers, Locked Nucleic Acid (LNA) RNA, siRNA/RNAi and CpG oligonucleotides. Purchase of the downloadable pdf report includes a 6-month online access to the data of ...
|
more...
|
$561.00
|
